PBM
HRTX icon

Propel Bio Management’s Heron Therapeutics HRTX Stock Holding History

Propel Bio Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-104,195
Closed -$177K – 33
2023
Q4 		$177K Buy
+104,195
New +$177K 0.15% 32